drugset / Trial / NCT06452953

Modified Suanzaoren Decoction Versus Eszopiclone for the Treatment of Chronic Insomnia Disorder

NCT06452953

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to observe the cognitive function and clinical efficacy of modified Suanzaoren decoction and eszopiclone in the treatment of chronic insomnia disorder patients, and to investigate the possible neural mechanisms using MRI techniques.

Timeline

Start
2020-09-10
Primary completion
2023-10-31
Completion
2024-03-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Eszopiclone Small molecule 1 mg
Subject Suanzaoren Decoction Traditional medicine (herbal / TCM)

Indications